pricing

News

Shares in Vertex jump on overnight success of CF triple ther...

Shares in US pharma Vertex were up sharply in premarket trading after its newly-launched cystic fibrosis triple therapy attained blockbuster status almost overnight, leading

Views & Analysis

Daiichi Sankyo: pharma needs to become NHS ‘experts’

If pharma wants to help the NHS improve outcomes, it needs to do so through a true partnership rather than a transactional relationship.

News

Pharma bad boy Shkreli asks for prison release to fight COVI...

Pharma bad boy Martin Shkreli has asked authorities to let him out of prison, saying that he could be the man to save the world from coronavirus.

News

Cost-concerns-with-the-new-NHS-pricing-scheme-2

Current pharma model “not sustainable” during COVID-19, says...

At eyeforpharma Daiichi Sankyo’s Manuel Reiberg spoke about why the industry should look to make drugs more affordable in the wake of the COVID-19 pandemic and “leave the next generation a healt

News

Gilead rescinds orphan status request for COVID-19 drug

Gilead has rescinded its request for orphan status for its potential COVID-19 antiviral remdesivir amid a furore over its pricing should it get to market.

News